Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2

Histone deacetylase 2 (HDAC2) is a chromatin modifier involved in epigenetic regulation of cell cycle, apoptosis and differentiation that is upregulated commonly in human hepatocellular carcinoma (HCC). In this study, we show that specific targeting of this HDAC isoform is sufficient to inhibit HCC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lee, Yun-Han, Seo, Daekwan, Choi, Kyung-Ju, Andersen, Jesper B., Won, Min-Ah, Kitade, Mitsuteru, Gómez-Quiroz, Luis E., Judge, Adam D., Marquardt, Jens U., Raggi, Chiara, Conner, Elizabeth A., MacLachlan, Ian, Factor, Valentina M., Thorgeirsson, Snorri S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4155016/
https://ncbi.nlm.nih.gov/pubmed/24958469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-3531
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados